Nebraska Hematology-Oncology (NHO) has received reaccreditation by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The QOPI® Certification Program provides a three-year certification for outpatient hematology-oncology practices that meet the highest standards for quality cancer care.
“All of us at Nebraska Hematology Oncology are extremely honored to receive reaccreditation from ASCO and QOPI. This designation highlights our continued commitment to excellence for our patients,” said Dr. Madhu Midathada.
NHO first achieved QOPI certification in April of 2011. This marked the first time a Nebraska clinic received this certification.
“Practices that choose to apply for recertification through QOPI demonstrate their continued commitment to the pursuit of clinical care excellence,” said ASCO President Clifford A. Hudis, MD, FACP. “The QOPI Certification Program helps such practices assess the level of care they provide to their patients and demonstrates their commitment to maintaining quality and lifelong learning.”
QOPI analyzes individual practice data and compares these to more than 160 evidence-based and consensus quality measures. The information is then provided in reports to participating practices. Individual practices are also able to compare their performance to data from other practices across the country. Based on this feedback, doctors and practices can identify areas for improvement.
About ASCO
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.
